Pune, India, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The global contract development and manufacturing organization market size is projected to reach USD 278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.
Request a Sample Copy of the Research Report
Industry Developments:
February 2019: Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for in the CNS therapeutic area.
Report Scope
| Report Coverage | Details |
| Forecast Period | 2019 to 2026 |
| Forecast Period 2019 to 2026 CAGR | 10.0 % |
| 2026 Value Projection | USD 278.98 Billion |
| Base Year | 2018 |
| Market Size in 2018 | USD 130.8 Billion |
| Historical Data for | 2015 to 2017 |
| No. of Pages | 155 |
| Key Players | Catalent, Inc , Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies |
| Growth Drivers | Increasing Demand for Pharmaceutical Products Will Aid Growth |
| Asia Pacific to Register Highest CAGR; Increasing Company Collaborations Will Aid Growth of the Regional Market | |
| Diverse Portfolio and Growing Focus on Mergers & Acquisition to Prove as Winning Strategy Leading Position in the Global Market |
Report Overview:
The contract development and manufacturing organization market is segmented on the basis of factors such as service and geographies. The report provides forecast values for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. The report highlights the latest product launches and labels major innovations in the market. In addition to this, it states the impact of these products on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
Product Overview:
A contract development and manufacturing organization (CDMO) helps healthcare companies for the development of drugs. It is involved in the overall process, right from the clinical trials till the commercialization and distribution of the drugs. The complexities in therapies and lack of in-house manufacturing capabilities will have a positive impact on the growth of the market in the coming years. The high investment in CDMOs will bode well for the overall market in the coming years. Moreover, the increasing number of strategic mergers and collaborations will contribute to the growth of the market. The use of advanced technologies in drug development processes will emerge in favor of the companies operating in the market.
Quick Buy Contract Development and Manufacturing Organization Market
https://www.fortunebusinessinsights.com/checkout-page/102502
Recipharm AB Introduces New Fully Integrated Service Platform
Accounting to the huge potential held by CDMOs, several companies are looking to invest more in the development of newer products. The huge investments have yielded a few exceptional products in recent years. In May 2019, Recipharm AB announced the launch of a fully integrated service platform for inhalation products. This will include the early stages of the products including the pre-clinical trials to the commercialization of the products. Recipharm’s latest product will generate huge sales and subsequently high revenues for the company. This will not just benefit the company, but will have a positive impact on the growth of the overall market in the coming years.
Asia Pacific to Register Highest CAGR; Increasing Company Collaborations Will Aid Growth of the Regional Market
The report analyses the ongoing CDMO market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific will register the highest CAGR in the coming years driven by the increasing number of company collaborations and mergers in several countries across the world. The market in North America is projected to emerge dominant in the coming years, owing to the presence of several well-established companies. As of 2018, the market in North America was worth USD 48.72 billion in 2018 and this value is projected to increase further in the coming years.
Get your Customized Research Report:
Contract Development and Manufacturing Organization Market Segmentations:
| Segmentation | By Service By CMO
|
By Geography
|
List of companies profiled in the report:
- Catalent, Inc
- Baxter
- Vetter
- Recipharm AB
- Albany Molecular Research Inc. (AMRI)
- Thermo Fisher Scientific Inc. (Patheon)
- Unither
- DPT LABORATORIES LTD.
- NextPharma Technologies
- Others
Have Any Query? Ask Our Experts
Table Of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments (Mergers, Acquisitions, & Partnerships,)
- The Regulatory Scenario for key countries/Regions
- Key Market Trends
- Key Services Mapping by Leading Players
- Global Contract Development and Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Service
- CMO
- API Manufacturing
- Finished Product Manufacturing
- Solid Dosage Forms
- Injectables
- Others (Semisolids/liquids, Powder)
- Packaging
- CRO
- Discovery
- Preclinical
- Clinical
- Laboratory Services
- CMO
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
ToC Continue…!
Frequently Asked Questions
How much is the contract development and manufacturing organization services market worth?
According to Fortune Business Insights, the global market was USD 130.80 billion in 2018 and is projected to reach USD 278.98 billion by 2026.
What is the leading segment in the CDMO market by service?
According to Fortune Business Insights, the CDMO segment is the leading segment in this market by service.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Address:
Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
